Investor Webinar – Update on Zelira’s progress with the FDA pre-IND meeting and HOPE SPV – Zelira Therapeutics

Zelira in the news

Articles

For media related enquiries please contact Damien Carbon at Profile Media
Ph: +61 (0) 412 332 122 E: damienc@profilemedia.com.au

Investor Webinar – Update on Zelira’s progress with the FDA pre-IND meeting and HOPE SPV

September 20, 2024